tDCS as Treatment for Motor Function (NCT07291687)
Transcranial Direct Current Stimulation as a Treatment for Motor Function in Participants Living With Progressive Supranuclear Palsy, Corticalbasal Syndrome Degeneration, or Parkinson's Disease
🩺 Plain-English Summary (8th-Grade Level)
Previous preliminary results are sufficiently impressive to suggest that tDCS stimulation does have the potential to improve motor function when that ability is trained during stimulation. In the proposed study, the investigation will assess whether walking sessions combined with tDCS lead to improvements in motor function: gait, articulation, eye gaze, and motor dexterity. In addition, the investigators wish to examine if such results can be replicated in people with other conditions, such as cortical basal syndrome, and Parkinson's disease.
Who can join: Review the eligibility criteria below.
Location: Baycrest Academy of Health Sciences and Geriatric Research — Toronto, Ontario
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Baycrest Academy of Health Sciences and Geriatric Research — Toronto, Ontario
📞 Contact the Study Coordinator
Phone: (416) 785-2500
Email: azhang4@research.baycrest.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Progressive Supranuclear Palsy
- Art Therapy in Progressive Supranuclear Palsy — Nashville, Tennessee
- A Study to Assess the Efficacy, Safety, and Pharmacokinetics of FNP-223 to Slow Progression of Progressive Supranuclear Palsy (PSP) — Carlsbad, California
- Remote Monitoring in Progressive Supranuclear Palsy (PSP) — Baltimore, Maryland
- A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy — Rochester, Minnesota
Explore by condition: All Progressive Supranuclear Palsy clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.